At Cyrano Therapeutics, we're dedicated to developing a therapy for people dealing with long-term smell and flavor loss. This condition was estimated to affect over 15 million people in the US alone before the COVID-19 pandemic, 4 million of whom had lost their smell due to the flu virus. Since the pandemic, the number of patients with long-term smell loss from a virus has increased more than 10-fold, with thousands of new patients emerging daily.